
MPEP
CAS No. 96206-92-7
MPEP ( —— )
产品货号. M19286 CAS No. 96206-92-7
MPEP 是一种选择性 mGlu5 受体拮抗剂,IC50 为 36 nM,对 mGlu1b/2/3/4a/7b/8a/6 受体没有明显的活性。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
10MG | ¥381 | 有现货 |
![]() ![]() |
25MG | ¥794 | 有现货 |
![]() ![]() |
50MG | ¥1458 | 有现货 |
![]() ![]() |
100MG | ¥2341 | 有现货 |
![]() ![]() |
200MG | ¥3848 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称MPEP
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述MPEP 是一种选择性 mGlu5 受体拮抗剂,IC50 为 36 nM,对 mGlu1b/2/3/4a/7b/8a/6 受体没有明显的活性。
-
产品描述MPEP is a selective mGlu5 receptor antagonist with IC50 of 36 nM, exhibits no appreciable activity at mGlu1b/2/3/4a/7b/8a/6 receptors.(In Vitro):MPEP does not show agonist or antagonist activity at 100 mM on human mGlu2, -3, -4a, -7b, and -8a receptors nor at 10 μM on the human mGlu6 receptor.(In Vivo):MPEP (1-30 mg/kg) induces anxiolytic-like effects in the conflict drinking test and the elevated plus-maze test in rats as well as in the four-plate test in mice.MPEP (1-20 mg/kg) does shorten the immobility time in a tail suspension test in mice, however it is inactive in the behavioural despair test in rats.MPEP (30 mg/kg i.p.) slightly but significantly increases (by 39%) the number of punished crossings in the four-plate test, lower doses of the compound (3 and 10 mg/kg) does not affect the number of punished crossings in that test (F (3,36)=3.240, P<0.05).MPEP (1, 10 and 20 mg/kg) significantly (by 55% after the highest dose), (F(3,28)=15.47, P<0.001) decreases the immobility time of mice in the tail suspension test. Its efficacy is similar to that of imipramine (20 mg/kg), used as the positive standard.
-
体外实验MPEP does not show agonist or antagonist activity at 100 mM on human mGlu2, -3, -4a, -7b, and -8a receptors nor at 10 μM on the human mGlu6 receptor.
-
体内实验MPEP (1-30 mg/kg) induces anxiolytic-like effects in the conflict drinking test and the elevated plus-maze test in rats as well as in the four-plate test in mice.MPEP (1-20 mg/kg) does shorten the immobility time in a tail suspension test in mice, however it is inactive in the behavioural despair test in rats.MPEP (30 mg/kg i.p.) slightly but significantly increases (by 39%) the number of punished crossings in the four-plate test, lower doses of the compound (3 and 10 mg/kg) does not affect the number of punished crossings in that test (F (3,36)=3.240, P<0.05). MPEP (1, 10 and 20 mg/kg) significantly (by 55% after the highest dose), (F(3,28)=15.47, P<0.001) decreases the immobility time of mice in the tail suspension test. Its efficacy is similar to that of imipramine (20 mg/kg), used as the positive standard. Animal Model:Male Wistar rats (200 ± 250 g).Dosage:IP or PO.Administration:0.3, 1 and 10 mg/kg, i.p. (Conflict drinking test).Result:At a dose of 0.3 mg/kg was not ffective, at doses of 1 and 10 mg/kg i.p. significantly (F (3,30)=11.193, P<0.001), increased the number of shocks (by 330 and 507%, respectively) accepted during the experimental session in the Vogel test. Animal Model:Male Wistar rats (200 ± 250 g).Dosage:IP or PO.Administration:1, 3 and 10 mg/kg, i.p. or 10 and 30 mg/kg, p.o.(Elevated plus-maze test).Result:Administered at a dose of 1 mg kg71 i.p. did not change the entries into and time spent in the open arms. At doses of 3 and 10 mg/kg i.p. significantly (F (3,24)=22.978, P<0.001) dose-dependently increased the time spent in the open arms (up to 45 and 74%, respectively), and the percentage of entries into the open arms (up to 48 and 68%, respectively, F(3,24)=5.678, P<.01). At doses of 3 and 10 mg/kg i.p. significantly increased (by 64%) the total number of entries and reduced (by about 25%) the total time spent (data not shown) in the arms (either type). At the dose of 30 mg/kg (po, but not 10 mg/kg) significantly (up to 64%, F (2,16)=14.249, P<0.001) increased the percentage of the time spent in the open arms and the percentage of entries into the open arms (up to 63%, F (2,16)=7.295, P<0.01). MPEP given p.o. in both doses used did not change the total number of entries nor the total time spent in the arms (either type).
-
同义词——
-
通路Others
-
靶点Other Targets
-
受体mGluR5
-
研究领域Neurological Disease
-
适应症——
化学信息
-
CAS Number96206-92-7
-
分子量193.24
-
分子式C14H11N
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 100 mg/mL (517.49 mM)
-
SMILESCC1=NC(=CC=C1)C#CC1=CC=CC=C1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Gasparini F, et al. Neuropharmacology, 1999, 38(10), 1493-1503.
产品手册




关联产品
-
EPI 743
EPI 743(Vatiquinone)是一种口服生物可利用的对苯醌,用于治疗遗传性线粒体疾病,是抗氧化剂泛癸利酮的类似物。
-
Ethoxyquin
抗氧化剂;还可以在收获后浸泡,以防止苹果和梨被烫伤。
-
Liensinine
莲心碱是一种异喹啉生物碱,具有拮抗室性心律失常的作用。